Table 1 |
|
|
Characteristics of the BOKS study population |
|
| Parameter |
Value |
|
|
|
| Age (years; mean ± SD [range]) |
67 ± 9 (50 to 93) |
| Sex (n [%] male) |
91 (60%) |
| Proportion with BML > 0 |
69.5% |
| NTx/Cr (nM/mM; mean ± SD) |
0.06 ± 0.12 |
| BSAP (U/l; mean ± SD) |
37.5 ± 23.2 |
| Osteocalcin (U/l; mean ± SD) |
19.2 ± 15.6 |
|
|
|
|
There were 151 participants. BOKS, Boston Osteoarthritis Knee Study; BSAP, bone-specific alkaline phosphatase; NTx/Cr, type I collagen N-telopeptide corrected for urinary creatinine; SD, standard deviation. |
|
|
Hunter et al. Arthritis Research & Therapy 2008 10:R102 doi:10.1186/ar2494 |
|
